Roberti Global was honored to join community leaders and partners in celebrating Eisai for receiving final regulatory approval for its new site in Baltimore, MD – the only site in the world that manufactures a specialized implant relied upon by thousands each year in the treatment of a rare form of brain cancer. This important milestone will help ensure continued access for patients worldwide.
